Vir Biotechnology, Inc.
Ticker: 1706431
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q1 FY2026 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 | Q3 FY2024 | Q2 FY2024 | Q1 FY2024 | Q3 FY2023 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | -0.03-112.5% | 0.24-80.2% | 1.21-60.1% | 3.03+27.3% | 2.38-22.7% | 3.08-94.5% | 56.38+2035.6% | 2.64 |
| Total Income | -0.03-112.5% | 0.24-80.2% | 1.21-60.1% | 3.03+27.3% | 2.38-22.7% | 3.08-94.5% | 56.38+2035.6% | 2.64 |
| EXPENSES | ||||||||
| Expenditure | 132.26-23.8% | 173.68+45.2% | 119.63-16.1% | 142.58-39.0% | 233.68+44.5% | 161.71+18.5% | 136.46-27.9% | 189.37 |
| Tax | 0.17+0.0% | 0.17+0.0% | 0.17+750.0% | 0.02-88.9% | 0.18+111.9% | -1.51-639.3% | 0.28+108.7% | -3.21 |
| PROFIT | ||||||||
| PBT | -125.53+23.0% | -162.97-47.1% | -110.79+8.4% | -120.95+43.4% | -213.54-52.6% | -139.89-115.2% | -65.00+61.0% | -166.63 |
| Net Profit | -125.70+22.9% | -163.14-47.0% | -110.96+8.3% | -120.97+43.4% | -213.72-54.4% | -138.38-112.0% | -65.28+60.1% | -163.41 |
| KEY METRICS | ||||||||
| OPM % | 100.00%+200.00pp | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| NPM % | 100.00%+200.00pp | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| EPS | -0.85+27.4% | -1.17-46.2% | -0.80+9.1% | -0.88+43.6% | -1.56-52.9% | -1.02-112.5% | -0.48+60.7% | -1.22 |
Corporate Events
Board MeetingVIR
20269Jun
Board Meeting
Board size increased from seven to eight members, and Timoth…
SEC Filing ↗ Board MeetingVIR
202626May
Board Meeting
Director Saira Ramasastry resigned, Robert More appointed Au…
SEC Filing ↗ Board MeetingVIR
202624Apr
Board Meeting
Mark Eisner, MD, MPH, Executive Vice President and Chief Med…
SEC Filing ↗